Use of 13-Valent Pneumococcal Conjugate Vaccine and 23-Valent Pneumococcal Polysaccharide Vaccine Among Adults Aged ≥65 Years: Updated Recommendations of the Advisory Committee on Immunization Practices | MMWR

Use of 13-Valent Pneumococcal Conjugate Vaccine and 23-Valent Pneumococcal Polysaccharide Vaccine Among Adults Aged ≥65 Years: Updated Recommendations of the Advisory Committee on Immunization Practices | MMWR

Use of 13-Valent Pneumococcal Conjugate Vaccine and 23-Valent Pneumococcal Polysaccharide Vaccine Among Adults Aged ≥65 Years: Updated Recommendations of the Advisory Committee on Immunization Practices

Weekly / November 22, 2019 / 68(46);1069–1075

Please note: An erratum has been published for this report. To view the erratum, please click here.

Almea Matanock, MD1; Grace Lee, MD2; Ryan Gierke, MPH1; Miwako Kobayashi, MD1; Andrew Leidner, PhD1; Tamara Pilishvili, PhD1 (View author affiliations)